HCW Biologics Inc. (HCWB)
2.44
-0.07
(-2.79%)
USD |
NASDAQ |
Sep 09, 11:22
HCW Biologics Profit Margin (Quarterly) : -11.34K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.34K% |
| March 31, 2026 | 19.19% |
| December 31, 2025 | -12.84K% |
| September 30, 2025 | -29.19K% |
| June 30, 2025 | -183.1K% |
| March 31, 2025 | -43.08K% |
| December 31, 2024 | -854.4% |
| September 30, 2024 | -915.2% |
| June 30, 2024 | -2.47K% |
| Date | Value |
|---|---|
| March 31, 2024 | -662.8% |
| December 31, 2023 | -806.7% |
| September 30, 2023 | -578.9% |
| June 30, 2023 | -691.1% |
| March 31, 2023 | -12.10K% |
| December 31, 2022 | -403.9% |
| September 30, 2022 | -216.4% |
| June 30, 2022 | -773.3% |
| March 31, 2022 | -65.99% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
| Anixa Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -802.4% |
| Return on Assets | -83.24% |
| Return on Invested Capital | -222.4% |
| Gross Profit Margin (Quarterly) | -163.0% |
| Operating Margin (Quarterly) | -2.34K% |
| Return on Net Operating Assets | -101.5% |